Skip to main content

Availability of Orkambi and other CF drugs on the NHS: further documents

30 January 2019

On Thursday 20 December the Health and Social Care Committee published documents received from Vertex Pharmaceuticals, NHS England and the National Institute for Health and Care Excellence (NICE) in response to its request.

The Committee invited the parties to make further comments on the documents the Committee received. These comments have now been made available below.

Further to the documents received, the Committee has announced a public hearing on the subject for Thursday 7 March. Anybody who wishes to bring information to the Committee's attention ahead of the session is invited to do so via the submission form.

Document from NHS England

Document from NICE

Documents from Vertex Pharmaceutical (Europe) Ltd

Further information

Image: iStockphoto